Company Filing History:
6 out of 22 
4 out of 108 
2 out of 2,597 
Years Active: 1999-2023
Title: The Innovations of C Richard Lyttle: A Pioneer in Osteoporosis Treatment
Introduction: C Richard Lyttle, an accomplished inventor based in Bala Cynwyd, Pennsylvania, has made significant contributions to the medical field with a total of 9 patents. His groundbreaking work particularly focuses on treatments for osteoporosis, showcasing innovative approaches that could enhance the quality of life for many patients.
Latest Patents: Among his notable inventions is a method of treating osteoporosis which involves the administration of a parathyroid hormone-related protein (PTHrP) analog. This invention presents a storage-stable composition containing PTHrP, allowing for convenient parenteral administration to human patients. The composition is designed to remain stable for several weeks at room temperature, thus simplifying treatment regimens. Additionally, he has developed therapeutic regimens involving the use of a specific compound, (R)-6-(2-(ethyl(4-(2-(ethylamino)ethyl)benzyl)amino)-4-methoxyphenyl)-5,6,7,8-tetrahydronaphthalen-2-ol, which underscores his focus on innovative solutions to complex medical challenges.
Career Highlights: Throughout his career, Lyttle has accumulated invaluable experience working at reputable companies in the pharmaceutical industry, including Radius Health, Inc. and Ipsen Pharma S.a.s. His expertise in drug formulation and therapeutic development has been instrumental in driving forward effective treatment options for osteoporosis.
Collaborations: Lyttle has collaborated with esteemed professionals in his field, including coworkers Bart Henderson and Michael J. Dey. These partnerships have fostered an environment of innovation, enhancing the potential for new therapies and driving research initiatives forward.
Conclusion: C Richard Lyttle's innovative patents and dedicated career in the medical industry illustrate his vital role in developing treatments for osteoporosis. As he continues to explore new methodologies and collaborate with fellow experts, his contributions promise to significantly impact patient care and the management of bone health.